DR. TRILOCHAN SATAPATHY

Employment

• Columbia Institute of Pharmacy Professor and HOD
  2010 - Present

Education

• Columbia Institute of Pharmacy M.Pharm (Gold Medal), Ph.D, D.Sc (Pharmacy),MBA (Education Management), FASc (AW),FIC
  2010 - Present

Projects & Funding

Projects & funding information is unavailable.

Publications (54)

• Helicobacter Pylori-induced Duodenal Ulcer: An Experimental Animal Model for Scientific Research
  Micro and Nanosystems 2025 DOI: 10.2174/0118764029337470241015100428
  +Save
• Experimental animal models for urolithiasis (kidney stone): A comprehensive review
  Animals and Zoonoses 2025 DOI: 10.1016/j.azn.2025.03.001
  +Save
• Janus Kinase Inhibitors (JAK) As Potential Candidate Targets to Rheumatoid Arthritis
  Current Research in Alternative Complementary & Integrative Medicine 2025
  +Save
• Dermal Safety Study and Antifungal activity of Dhatrayadi lepa
  Int.J.Pharm.Investigation 2025
  +Save
• Recent outbreaks of Human Metapneumovirus (HMPV): Prevention, Diagnosis and Therapeutic insights
  Journal of Drug Delivery and Therapeutics 2025
  +Save
• Recent outbreaks of Human Metapneumovirus (HMPV): Prevention, Diagnosis and Therapeutic insights
  Journal of Drug Delivery and Therapeutics 2025 DOI: 10.22270/jddt.v15i2.7000
  +Save
• Experimental animal models for urolithiasis (kidney stone): A comprehensive review
  Animals and Zoonoses 2025
  +Save
• A Comprehensive Review on Novel Therapies for Gastrointestinal Cancers using Translational Platforms
  Current Pharmaceutical Design 2025
  +Save
• Metabolic dysfunction-associated steatotic liver disease (MASLD): Exploring systemic impacts and innovative therapies
  Clinics and Research in Hepatology and Gastroenterology 2025
  +Save
• Recent Progress on Acrylamide-Induced Programmed Cell Death (PCD) in Safety Drug Development
  PROBECELL SCIENCE 2025
  +Save